SC 13G/A: Coherus BioSciences, Inc.
Ticker: CHRS · Form: SC 13G/A · Filed: May 22, 2024 · CIK: 1512762
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Coherus BioSciences, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,534 words · 6 min read · ~5 pages · Grade level 10.7 · Accepted 2024-05-22 19:27:00
Key Financial Figures
- $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- d824356dsc13ga.htm (SC 13G/A) — 85KB
- d824356dex991.htm (EX-99.1) — 9KB
- 0001193125-24-145183.txt ( ) — 96KB
From the Filing
SC 13G/A 1 d824356dsc13ga.htm SC 13G/A SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Coherus BioSciences, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 19249H103 (CUSIP Number) May 20, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.19249H103 Page 2 of 9 1 NAMES OF REPORTING PERSONS Temasek Holdings (Private) Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of Singapore NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 6,220,552 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 6,220,552 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,220,552 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% (1) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC (1) Based on 114,725,740 shares of the Issuers common stock outstanding as of April 30, 2024, as set forth in the Issuers (as defined herein) quarterly report on Form 10-Q filed with the Securities and Exchange Commission (the Commission) on May 9, 2024. CUSIP No.19249H103 Page 3 of 9 1 NAMES OF REPORTING PERSONS Fullerton Management Pte Ltd 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of Singapore NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 6,220,552 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 6,220,552 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,220,552 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% (1) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC (1) Based on 114,725,740 shares of the Issuers common stock outstanding as of April 30, 2024, as set forth in the Issuers quarterly report on Form 10-Q filed with the Commission on May 9, 2024. CUSIP No.19249H103 Page 4 of 9 1 NAMES OF REPORTING PERSONS Temasek Life Sciences Private Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of Singapore NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 6,220,552 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 6,220,552 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,220,552 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% (1) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) HC (1) Based on 114,725,740 shares of the Issuers common stock outstanding as of April 30, 2024, as set forth in the Issuers quarterly report on Form 10-Q filed with the Commission on May 9, 2024. CUSIP No.19249H103 Page 5 of 9 1 NAMES OF REPORTING PERSONS V-Sciences Investments Pte Ltd 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of Singapore NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 6,220,552 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 6,220,552 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,220,552 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% (1) 12 TYPE OF REPORTING PERSON (SEE INS